Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Drug Repurposing for the Treatment of Bacterial and Fungal Infections.

Miró-Canturri A, Ayerbe-Algaba R, Smani Y.

Front Microbiol. 2019 Jan 28;10:41. doi: 10.3389/fmicb.2019.00041. eCollection 2019. Review.

2.

Relationship Between Different Resistance Mechanisms and Virulence in Acinetobacter baumannii.

Espinal P, Pantel A, Rolo D, Marti S, López-Rojas R, Smani Y, Pachón J, Vila J, Lavigne JP.

Microb Drug Resist. 2019 Jun;25(5):752-760. doi: 10.1089/mdr.2018.0182. Epub 2019 Jan 11.

PMID:
30632884
3.

Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii.

Fernandez-Garcia L, Ambroa A, Blasco L, Bleriot I, López M, Alvarez-Marin R, Fernández-Cuenca F, Martinez-Martinez L, Vila J, Rodríguez-Baño J, Garnacho-Montero J, Cisneros JM, Pascual A, Pachón J, Bou G, Smani Y, Tomás M.

Front Microbiol. 2018 Dec 17;9:3105. doi: 10.3389/fmicb.2018.03105. eCollection 2018.

4.

In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae.

Cebrero-Cangueiro T, Álvarez-Marín R, Labrador-Herrera G, Smani Y, Cordero-Matía E, Pachón J, Pachón-Ibáñez ME.

Front Cell Infect Microbiol. 2018 Oct 18;8:363. doi: 10.3389/fcimb.2018.00363. eCollection 2018.

5.

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae.

Ayerbe-Algaba R, Gil-Marqués ML, Jiménez-Mejías ME, Sánchez-Encinales V, Parra-Millán R, Pachón-Ibáñez ME, Pachón J, Smani Y.

Front Cell Infect Microbiol. 2018 Oct 3;8:348. doi: 10.3389/fcimb.2018.00348. eCollection 2018.

6.

Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.

Parra-Millán R, Vila-Farrés X, Ayerbe-Algaba R, Varese M, Sánchez-Encinales V, Bayó N, Pachón-Ibáñez ME, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y.

J Antimicrob Chemother. 2018 Dec 1;73(12):3405-3412. doi: 10.1093/jac/dky343.

PMID:
30188994
7.

Escherichia coli causing meningitis in an adult: A case report and experimental characterization of its virulence.

Ayerbe Algaba R, Álvarez-Marín R, Praena J, Smani Y.

Enferm Infecc Microbiol Clin. 2019 Jun - Jul;37(6):418-419. doi: 10.1016/j.eimc.2018.06.002. Epub 2018 Jul 6. English, Spanish. No abstract available.

PMID:
30115543
8.

Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection.

Gil-Marqués ML, Pachón-Ibáñez ME, Pachón J, Smani Y.

Infect Immun. 2018 Sep 21;86(10). pii: e00543-18. doi: 10.1128/IAI.00543-18. Print 2018 Oct.

9.

Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae.

Pachón-Ibáñez ME, Labrador-Herrera G, Cebrero-Cangueiro T, Díaz C, Smani Y, Del Palacio JP, Rodríguez-Baño J, Pascual A, Pachón J, Conejo MC.

Front Microbiol. 2018 May 15;9:912. doi: 10.3389/fmicb.2018.00912. eCollection 2018.

10.

Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB.

Parra-Millán R, Guerrero-Gómez D, Ayerbe-Algaba R, Pachón-Ibáñez ME, Miranda-Vizuete A, Pachón J, Smani Y.

mSphere. 2018 Mar 28;3(2). pii: e00106-18. doi: 10.1128/mSphere.00106-18. eCollection 2018 Mar-Apr.

11.

Combating virulence of Gram-negative bacilli by OmpA inhibition.

Vila-Farrés X, Parra-Millán R, Sánchez-Encinales V, Varese M, Ayerbe-Algaba R, Bayó N, Guardiola S, Pachón-Ibáñez ME, Kotev M, García J, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y.

Sci Rep. 2017 Oct 31;7(1):14683. doi: 10.1038/s41598-017-14972-y.

12.

Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.

Rodríguez-Villodres Á, Ortiz de la Rosa JM, Álvarez-Marín R, Pachón J, Aznar J, Lepe JA, Smani Y.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01923-17. doi: 10.1128/AAC.01923-17. Print 2018 Jan. No abstract available.

13.

Comparison of the in vitro activity of ampicillin and moxifloxacin against Listeria monocytogenes at achievable concentrations in the central nervous system.

Pupo I, Lepe JA, Smani Y, Aznar J.

J Med Microbiol. 2017 Jun;66(6):713-720. doi: 10.1099/jmm.0.000486. Epub 2017 Jun 9.

PMID:
28598305
14.

Perspectives for clinical use of engineered human host defense antimicrobial peptides.

Pachón-Ibáñez ME, Smani Y, Pachón J, Sánchez-Céspedes J.

FEMS Microbiol Rev. 2017 May 1;41(3):323-342. doi: 10.1093/femsre/fux012. Review.

15.

Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase.

Sánchez-Encinales V, Álvarez-Marín R, Pachón-Ibáñez ME, Fernández-Cuenca F, Pascual A, Garnacho-Montero J, Martínez-Martínez L, Vila J, Tomás MM, Cisneros JM, Bou G, Rodríguez-Baño J, Pachón J, Smani Y.

J Infect Dis. 2017 Mar 15;215(6):966-974. doi: 10.1093/infdis/jix010.

PMID:
28453834
16.

Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.

Domínguez-Herrera J, López-Rojas R, Smani Y, Labrador-Herrera G, Pachón J.

Int J Antimicrob Agents. 2016 Dec;48(6):661-665. doi: 10.1016/j.ijantimicag.2016.09.011. Epub 2016 Oct 18.

PMID:
28128094
17.

Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.

Parra Millán R, Jiménez Mejías ME, Sánchez Encinales V, Ayerbe Algaba R, Gutiérrez Valencia A, Pachón Ibáñez ME, Díaz C, Pérez Del Palacio J, López Cortés LF, Pachón J, Smani Y.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4464-70. doi: 10.1128/AAC.02708-15. Print 2016 Aug.

18.

New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.

Smani Y, Pachón-Ibáñez ME, Pachón J.

Expert Opin Pharmacother. 2016 Jun;17(9):1207-14. doi: 10.1080/14656566.2016.1176144. Epub 2016 Apr 28. Review.

PMID:
27067283
19.

Draft Genome Sequences of Seven Multidrug-Resistant Acinetobacter baumannii Strains, Isolated from Respiratory Samples in Spain.

Labrador-Herrera G, Álvarez R, López-Rojas R, Smani Y, Cebrero-Cangueiro T, Rueda A, Pérez Florido J, Pachón J, Pachón-Ibáñez ME.

Genome Announc. 2016 Mar 31;4(2). pii: e00083-16. doi: 10.1128/genomeA.00083-16.

20.

Use of adjuvants in the treatment of Acinetobacter baumannii.

Pachón-Ibáñez ME, Smani Y, Pachón J.

Expert Rev Anti Infect Ther. 2016;14(2):153-5. doi: 10.1586/14787210.2016.1126508. Epub 2015 Dec 19.

PMID:
26620637
21.

Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii.

Smani Y, Domínguez-Herrera J, Ibáñez-Martínez J, Pachón J.

Antimicrob Agents Chemother. 2015 Jul;59(7):3920-4. doi: 10.1128/AAC.04986-14. Epub 2015 Apr 20.

22.

Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii.

Smani Y, Fàbrega A, Roca I, Sánchez-Encinales V, Vila J, Pachón J.

Antimicrob Agents Chemother. 2014;58(3):1806-8. doi: 10.1128/AAC.02101-13. Epub 2013 Dec 30.

23.

In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes.

Lepe JA, Torres MJ, Smani Y, Parra-Millán R, Pachón J, Vazquez-Barba I, Aznar J.

Int J Antimicrob Agents. 2014 Feb;43(2):135-9. doi: 10.1016/j.ijantimicag.2013.10.018. Epub 2013 Nov 19.

PMID:
24315790
24.

Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii.

Smani Y, Dominguez-Herrera J, Pachón J.

J Infect Dis. 2013 Nov 15;208(10):1561-70. doi: 10.1093/infdis/jit386. Epub 2013 Aug 1.

PMID:
23908480
25.

Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.

López-Rojas R, Smani Y, Pachón J.

Expert Rev Anti Infect Ther. 2013 Mar;11(3):231-3. doi: 10.1586/eri.13.11. Review. No abstract available.

PMID:
23458763
26.

Loss of the OprD homologue protein in Acinetobacter baumannii: impact on carbapenem susceptibility.

Smani Y, Pachón J.

Antimicrob Agents Chemother. 2013 Jan;57(1):677. doi: 10.1128/AAC.01277-12. No abstract available.

27.

Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells.

Smani Y, Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J, Ibáñez-Martínez J, Pachón J.

J Biol Chem. 2012 Aug 3;287(32):26901-10. doi: 10.1074/jbc.M112.344556. Epub 2012 Jun 11.

28.

Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells.

Smani Y, McConnell MJ, Pachón J.

PLoS One. 2012;7(4):e33073. doi: 10.1371/journal.pone.0033073. Epub 2012 Apr 13.

29.

Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.

Docobo-Pérez F, Nordmann P, Domínguez-Herrera J, López-Rojas R, Smani Y, Poirel L, Pachón J.

Int J Antimicrob Agents. 2012 Mar;39(3):251-4. doi: 10.1016/j.ijantimicag.2011.10.012. Epub 2011 Dec 7.

PMID:
22154856
30.

In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii.

Smani Y, López-Rojas R, Domínguez-Herrera J, Docobo-Pérez F, Martí S, Vila J, Pachón J.

Clin Microbiol Infect. 2012 Jan;18(1):E1-4. doi: 10.1111/j.1469-0691.2011.03695.x. Epub 2011 Nov 15.

31.

Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like.

Fernández-Cuenca F, Smani Y, Gómez-Sánchez MC, Docobo-Pérez F, Caballero-Moyano FJ, Domínguez-Herrera J, Pascual A, Pachón J.

Int J Antimicrob Agents. 2011 Dec;38(6):548-9. doi: 10.1016/j.ijantimicag.2011.08.002. Epub 2011 Sep 21. No abstract available.

PMID:
21940150
32.

Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii.

Smani Y, Domínguez-Herrera J, Pachón J.

J Infect Dis. 2011 Apr 15;203(8):1110-9. doi: 10.1093/infdis/jiq159. Epub 2011 Feb 28.

PMID:
21357946
33.

Acinetobacter baumannii-induced lung cell death: role of inflammation, oxidative stress and cytosolic calcium.

Smani Y, Docobo-Pérez F, McConnell MJ, Pachón J.

Microb Pathog. 2011 May;50(5):224-32. doi: 10.1016/j.micpath.2011.01.008. Epub 2011 Feb 1.

PMID:
21288481
34.

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

López-Rojas R, Domínguez-Herrera J, McConnell MJ, Docobo-Peréz F, Smani Y, Fernández-Reyes M, Rivas L, Pachón J.

J Infect Dis. 2011 Feb 15;203(4):545-8. doi: 10.1093/infdis/jiq086. Epub 2011 Jan 7.

35.

Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.

McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F, Pachón J.

Infect Immun. 2011 Jan;79(1):518-26. doi: 10.1128/IAI.00741-10. Epub 2010 Oct 25.

37.

[Hemoglobin-based oxygen carriers and trials to substitute red blood cells].

Smani Y, Labrude P, Vigneron C, Faivre B.

Transfus Clin Biol. 2007 Nov;14(5):464-73. doi: 10.1016/j.tracli.2007.12.007. Epub 2008 Mar 4. Review. French.

PMID:
18295525
38.

[Blood substitutes: state of the art and technical setbacks and why we are still disappointed].

Vigneron C, Smani Y, Faivre B.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):837-47; discussion 847. Review. French.

PMID:
18225438
39.

Pharmacological and physicochemical factors in the pressor effects of conjugated haemoglobin-based oxygen carriers in vivo.

Smani Y, Fifre A, Labrude P, Vigneron C, Faivre B.

J Hypertens. 2007 Mar;25(3):599-608.

PMID:
17278977
40.

[Potential mechanism of dextran-conjugated hemoglobin penetration inside arterial wall].

Smani Y, Faivre B, Fries I, Labrude P, Vigneron C.

Arch Mal Coeur Vaiss. 2006 Jul-Aug;99(7-8):722-6. French.

PMID:
17061452
41.

Resuscitation of severe but brief haemorrhagic shock with PFC in rabbits restores skeletal muscle oxygen delivery and does not alter skeletal muscle metabolism.

Audonnet-Blaise S, Krafft MP, Smani Y, Mertes PM, Marie PY, Labrude P, Longrois D, Menu P.

Resuscitation. 2006 Jul;70(1):124-32. Epub 2006 Jun 8.

PMID:
16759782
42.

[Relationship between arterial pressure evolution and free hemoglobin distribution into vascular wall in guinea pigs].

Smani Y, Faivre B, Audonnet-Blaise S, Labrude P, Vigneron C.

Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):821-4. French.

PMID:
16220754
43.

Hemoglobin-based oxygen carrier distribution inside vascular wall and arterial pressure evolution: is there a relationship?

Smani Y, Faivre B, Audonnet-Blaise S, Labrude P, Vigneron C.

Eur Surg Res. 2005 Jan-Feb;37(1):1-8.

PMID:
15818035

Supplemental Content

Support Center